Here's Why DaVita HealthCare (DVA) is a Strong Value Stock

DaVita Healthcare (DVA), a leading dialysis service provider, is highlighted as a potentially strong value stock by Zacks, currently holding a Zacks Rank #3 (Hold) and a VGM Score of B. The company's Value Style Score of A is supported by an attractive forward P/E ratio of 12.68, and the consensus earnings estimate for fiscal year 2025 has increased to $10.76 per share following an analyst revision, suggesting possible upside for value investors.

Analysis

DaVita Inc. (DVA), a leading U.S. dialysis service provider, currently holds a Zacks Rank #3 (Hold), suggesting market-neutral performance expectations. Despite this, DVA exhibits compelling value attributes, highlighted by a top-tier Value Style Score of 'A' and an attractive forward P/E ratio of 12.68. The company also scores a 'B' in the overall VGM (Value, Growth, Momentum) category. Further positive indicators include an upward earnings estimate revision for fiscal year 2025 from one analyst within the last 60 days, with the Zacks Consensus Estimate for fiscal year 2025 EPS at $10.76, and a track record of delivering an average earnings surprise of 3.6%. According to Zacks' methodology, a #3 ranked stock coupled with strong Style Scores (A or B) can still present upside potential, positioning DVA as a noteworthy candidate for value-focused investors.

Key Decisions for Investors

• Investors with a value-oriented strategy should consider DaVita (DVA) due to its 'A' Value Style Score and attractive forward P/E ratio of 12.68, despite its current Zacks #3 (Hold) rating.
• It is advisable to closely monitor future earnings estimate revisions for DVA, as positive changes are key drivers for Zacks Rank upgrades and could signal strengthening fundamentals or an improved outlook.
• Given the neutral 'Hold' rating, investors might exercise patience, but the strong 'B' VGM score and positive analyst sentiment suggest DVA warrants inclusion on a watchlist for potential portfolio addition should further positive catalysts or improved earnings momentum emerge.